 SEATTLE, WA and VANCOUVER, BC ACCESSWIRE March 15, 2021 Achieve Life Sciences, Inc. NASDAQ:ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, is pleased to announce the appointment of Dr. Bridget Martell and Dr. Cindy Jacobs to the companys Board of Directors, effective immediately. We are excited to welcome Dr. Martell and Dr. Jacobs to the board, commented Rick Stewart, Achieves Executive Chairman of the Board of Directors. 